Molecular Diagnostics

Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, sub classification, prognosis, and monitoring response to therapy. Molecular diagnostics is the outcome of the fruitful interplay among laboratory medicine, genomics knowledge, and technology in the field of molecular genetics, especially with significant discoveries in the field of molecular genomic technologies.

The department of Molecular Diagnostics is responsible for performing molecular diagnostic tests for nucleic acid targets found in a variety of settings in medicine. We offer a wide array of tests at the forefront of molecular diagnostics.

We also perform RT-PCR Tests. Real time RT–PCR is a nuclear-derived method for detecting the presence of specific genetic material in any pathogen, including a virus. Originally, the method used radioactive isotope markers to detect targeted genetic materials, but subsequent refining has led to the replacement of isotopic labelling with special markers, most frequently fluorescent dyes. This technique allows scientists to see the results almost immediately while the process is still ongoing. Real time RT–PCR is one of the most widely used laboratory methods for detecting the COVID-19 virus.

Tests in Molecular Diagnostics include:

• ANA
• BCR/ ABL- Mutation
• Chikungunya
• CMV (Qualitative)
• CMV (Quantitative)
• Dengue
• Dengue Chikungunya Combo
• FISH Her2neu (Fluorescence in situ hybridization)
• Fluorescent Treponemal Antibody (FTA)
• H1N1 Swine flu
• HBV DNA (Qualitative)
• HBV DNA (Quantitative)
• HCV (Qualitative)
• HCV (Quantitative)
• HIV (Qualitative)
• HIV (Quantitative) Viral Load
• HLA B27
• HPV High risk
• HSV (Qualitative)
• HSV (Quantitative)
• IHC CD markers
• IHC CK-20
• IHC CK-7
• IHC ER-PR
• IHC ER-PR-Her2neu
• IHC Ki-67
• Influenza A & B type
• JAK-2 Mutation
• MTB (Qualitative)
• MTB (Quantitative)
• SARS-Cov-2 (COVID)